Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journal
Impact of smoking history on the outcomes of women with early-stage breast cancer: a secondary analysis of a randomized study Medical Oncology
Impact of timeliness of adjuvant chemotherapy and radiotherapy on the outcomes of breast cancer; a pooled analysis of three clinical trials The Breast
Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study Journal of Cancer Research and Clinical Oncology
External validation of the prostascore model inpatients with metastatic hormone-sensitive prostate cancer recruited to the CHAARTED study BJU International
On the relationship between tumour growth rate and survival in non-small cell lung cancer PeerJ
Using complex networks for refining survival prognosis in prostate cancer patient F1000 Research
Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approach F1000 Research
Survival prognosis and variable selection: A case study for metastatic castrate resistant prostate cancer patients F1000 Research
Two-step feature selection for predicting survival time of patients with metastatic castrate resistant prostate cancer F1000 Research
Effect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up Radiation Oncology
Community mining of open clinical trial data Oncotarget
Project Data Sphere to Make Cancer Clinical Trial Data Publicly Available Journal of the National Cancer Institute
A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer Journal of Clinical Oncology
Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients F1000 Research

Pages